Oversold

PGNY

Valuation86/ 100
Cash flow & growth74/ 100
Upside potential77/ 100
Risk potential20/ 100

PGNY's valuation is historically cheap, fundamentals are above averages and forward estimates point to earnings and revenue growth, though analyst coverage is limited.

Score change since last week

The score rose 9 points, mainly due to valuation and price changes. Price fell 0.2%, from $26.00 to $25.94. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 9.2 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 29.7× versus the full-history median of 52.7× shown in the valuation table, producing 81.8/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 86.1/100. The model applies a 34.9% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 37.2× (18-month half-life). The favorable scenario uses 36.5× PE and $1.3 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +5.5%, earnings +55.9%, operating margin +2.4 percentage points. Free cash flow is 16.6% of revenue. The business score is 73.7/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $1.34 of EPS and a 36.5× PE, suggesting a share price of about $48.78. Valuation history and outlook inform the PE.

The displayed favorable scenario is 78.3% upside, or about $48.77.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.80 of EPS and a 27.3× PE, suggesting a share price of about $21.98 — 20% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

PGNY vs Historical averages

MetricCurrentAverageRelative
PE30x166x82% lower
PE percentile115079% lower
EPS$0.92$0.5761% higher
FCF$218M$117.7M85% higher
Loading historical comparisons…

PGNY’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

PGNY Forward outlook

MetricOutlook
Forward valuationStrongly improving
Forward earningsStrong growth
Forward revenueGrowth
Forward profitabilityStable
Analyst coverageLimited
Estimate dispersionTight

PGNY’s outlook is generally improving, though analyst coverage is limited.

PGNY PE Valuation

Loading pe valuation table…

This table applies PGNY's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

PGNY Earnings Per Share

Loading earnings per share…

This chart tracks PGNY's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

PGNY Quarterly Revenue

Loading quarterly revenue…

This chart tracks PGNY's quarterly revenue over time and shows how sales are changing from year to year.

PGNY Free Cash Flow

Loading free cash flow…

This chart tracks PGNY's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

PGNY Total Shares

Loading shares over time…

This chart tracks changes in PGNY's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

PGNY Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

PGNY PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares PGNY's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

PGNY Weekly Price

Loading weekly price…

This chart uses PGNY's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

PGNY Weekly Moving Averages

Loading weekly moving averages…

This chart compares PGNY's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

PGNY Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.